| Card | Table | RUSMARC | |
|
|
Heterocyclic Anticancer Agents [[electronic resource]] / edited by Bimal Krishna Banik and Bubun Banerjee. — Berlin/Boston: Walter de Gruyter GmbH, 2022. — 1 online resource (532 p.). — Description based upon print version of record. — <URL:http://elib.fa.ru/ebsco/3307562.pdf>.Record create date: 8/13/2022 Subject: Antineoplastic agents.; Cancer — Treatment.; Heterocyclic compounds. Collections: EBSCO Allowed Actions: –
Action 'Read' will be available if you login or access site from another network
Action 'Download' will be available if you login or access site from another network
Group: Anonymous Network: Internet |
Document access rights
| Network | User group | Action | ||||
|---|---|---|---|---|---|---|
| Finuniversity Local Network | All |
|
||||
| Internet | Readers |
|
||||
|
Internet | Anonymous |
Table of Contents
- Preface
- Contents
- List of contributing authors
- 1 Naturally occurring, natural product inspired and synthetic heterocyclic anti-cancer drugs
- 2 Naturally occurring heterocyclic anticancer compounds
- 3 Lawsone (2-hydroxy-1,4-naphthaquinone) derived anticancer agents
- 4 Advances in heterocycles as DNA intercalating cancer drugs
- 5 Recent advances of heterocycle based anticancer hybrids
- 6 Fused pyrrolo-pyridines and pyrrolo-(iso) quinoline as anticancer agents
- 7 Updates on the versatile quinoline heterocycles as anticancer agents
- 8 Recent development of imidazole derivatives as potential anticancer agents
- 9 Recent developments in the synthesis and anti-cancer activity of acridine and xanthine-based molecules
- 10 Synthesis of new horizons in benzothiazole scaffold and used in anticancer drug development
- 11 Triazine based chemical entities for anticancer activity
- 12 Anticancer properties of arylchromenes and arylchromans: an overview
- 13 Anticancer potential of indole derivatives: an update
- 14 Indole based prostate cancer agents
- Index
Usage statistics
|
|
Access count: 0
Last 30 days: 0 Detailed usage statistics |